Genotype, phenotype and cancer: Role of low penetrance genes and environment in tumour susceptibility

Journal of Biosciences

Volumn 30, Issue 1, 2005, Pages 93-102

  Kotnis, Ashwin ^a   Sarin, Rajiv ^a   Mulherkar, Rita ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Gene environment interactions; Low penetrance genes; Multiple primary cancers; SNP

Indexed keywords

APC PROTEIN; BRCA1 PROTEIN; CARCINOGEN; PROTEIN RET;

CANCER;

AMINO ACID SUBSTITUTION; BLADDER CANCER; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD CANCER; HEREDITY; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MALIGNANT TRANSFORMATION; NECK CANCER; ONCOGENE; PATHOPHYSIOLOGY; PENETRANCE; PHENOTYPE; PRECANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; UTERUS CANCER;

NICOTIANA TABACUM;

EID: 17644419976     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02705154     Document Type: Conference Paper

References (72)

1. Aka P, Mateuca R, Buchet J P, Thierens H and Kirsch-Volders M 2004 Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat. Res. 556 169-181
2. Balmain A, Gray J and Ponder B 2003 The Genetics and Genomics of Cancer; Nature Genet. 33 238
3. Barcellos-Hoff M H 2001 It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment; J. Mammary Gland Biol. Neoplasia 6 213-221
4. Bhowmick N A, Chytil A, Plieth D, Gorska A E, Dumont N, Shappell S, Washington M K, Neilson E G and Moses H L 2004 TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia; Science 303 848-851
5. Bostwick D G, Burke H B, Djakiew D, Euling S, Ho S M, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters D J and Timms B 2004 Human prostate cancer risk factors; Cancer Oct. 19
6. Brennan P 2002 Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 23 381-387
7. Buch S C, Notani P N and Bhisey R A 2002 Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population; Carcinogenesis 23 803-807
8. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane C R, Lim E P, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley G Q and Lander E S 1999 Characterization of single nucleotide polymorphisms in coding regions of human genes; Nature Genet. 22 231-238
9. Chen Q, Lipkina G, Song Q and Kramer R H 2004 Promoter methylation regulates cadherin switching in squamous cell carcinoma; Biochem. Biophys. Res. Commun. 315 850-856
10. Chow E, Thirlwell C, Macrae F and Lipton L 2004 Colorectal cancer and inherited mutations in base-excision repair; Lancet Oncol. 5 600-606
11. Costello J F and Plass C 2001 Methylation matters; J. Med. Genet. 38 285-303
12. Cybulski C, Huzarski T, Gorski B, Masojc B, Mierzejewski M, Debniak T, Gliniewicz B, Matyjasik J, Zlowocka E, Kurzawski G, Sikorski A, Posmyk M, Szwiec M, Czajka R, Narod S A and Lubinski J 2004 A novel founder CHEK2 mutation is associated with increased prostate cancer risk; Cancer Res. 64 2677-2679
13. Day G L, Blot W J, Shore R E, McLaughlin J K, Austin D F, Greenberg R S, Liff J M, Preston-Martin S, Sarkar S and Schoenberg J B et al 1994 Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol; J. Natl. Cancer Inst. 86 131-137
14. Doll R 1975 Pott and the path to prevention; Arch. Geschwulstforsch. 45 521-531
15. Etze C J, Amos C I and Spitz M R 2003 Risk for smoking-related cancer among relatives of lung cancer patients; Cancer Res. 63 8531-8535
16. Evan G I and Vousden K H 2001 Proliferation, cell cycle and apoptosis in cancer; Nature (London) 411 342-348
17. Fan R, Wu M T, Miller D, Wain J C, Kelsey K T, Wiencke J K and Christiani D C 2000 The p53 codon 72 polymorphism and lung cancer risk; Cancer Epidemiol. Biomarkers Prev. 9 1037-1042
18. Fearon E R 1997 Human cancer syndromes: clues to the origin and nature of cancer; Science 278 1043-1050
19. Fujita M, Rudoltz M S, Canady D J, Patel P, Machtay M, Pittard M Q, Mohiuddin M and Regine W F 1998 Second malignant neoplasia in patients with T1 glottic cancer treated with radiation; Laryngoscope 108 1853-1855
20. Futreal P, Andrew, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N and Stratton M R 2004 A census of human cancer genes; Nature Rev. Cancer 4 177
21. Han D F, Zhou X, Hu M B, Wang C H, Xie W, Tan X D, Zheng F and Liu F 2004 Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women; Toxicol. Lett. 150 167-177
22. Hanahan D and Weinberg R A 2000 The hallmarks of cancer; Cell 100 57-70
23. Hashibe M, Brennan P, Strange R C, Bhisey R, Cascorbi I, Lazarus P, Oude Ophuis M B, Benhamou S, Foulkes W D, Katoh T, Coutelle C, Romkes M, Gaspari L, Taioli E and Boffetta P 2003 Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer; Cancer Epidemiol. Biomarkers Prev. 12 1509-1517
24. Hein D W, Doll M A, Fretland A J, Leff M A, Webb S J, Xiao G H, Devanaboyina U S, Nangju N A and Feng Y 2000 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms; Cancer Epidemiol. Biomarkers Prev. 9 29-42
25. Hemminki K and Shields P G 2002 Skilled use of DNA polymorphisms as a tool for polygenic cancers; Carcinogenesis 23 379-380
26. Houlston R S and Peto J 2004 The search for low-penetrance cancer susceptibility alleles; Oncogene 23 6471-6476
27. Howe J R, Roth S, Ringold J C, Summers R W, Jarvinen H J, Sistonen P, Tomlinson I P, Houlston R S, Bevan S, Mitros F A, Stone E M and Aaltonen L A 1998 Mutations in the SMAD4/ DPC4 gene in juvenile polyposis; Science 280 1086-1088
28. Hsieh F I, Pu Y S, Chern H D, Hsu L I, Chiou H Y and Chen C J 1999 Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer; Br. J. Cancer 81 537-541
29. Imyanitov E N, Togo A V and Hanson K P 2004 Searching for cancer-associated gene polymorphisms: promises and obstacles; Cancer Lett. 204 3-14
30. Ishikawa T, Ide F, Qin X, Zhang S, Takahashi Y, Sekiguchi M, Tanaka K and Nakastsuru Y 2001 Importance of DNA repair in Carcinogenesis: evidence from transgenic and gene targeting studies; Mutat. Res. 477 41-49
31. Jhavar S, Sarin R, Mulherkar R, Benner A, Agarwal J P and Dinshaw K 2004 Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco; Oral Oncol. 40 84-91
32. KinzlerK W and Vogelstein B 1998 Landscaping the cancer terrain; Science 15 1036-1037
33. Knudson A G 2002 Cancer Genetics; Am. J. Med. Genet: 111 96-102
34. Lander E S, Linton L M, Birren B et al 2001 Initial sequencing and analysis of the human genome; Nature (London) 409 860-921
35. Lichtenstein P, Holm N V, Verkasalo P K, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki K 2000 Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland; N. Engl. J. Med. 343 78-85
36. London S J, Yuan J-M, Coetzee G A, Gao Y T, Ross R K and Yu M C 2000 CYP1A1 I462V Genetic Polymorphism and Lung Cancer Risk in a Cohort of Men in Shanghai, China; Cancer Epidemiol. Biomarkers Prevention 9 987-991
37. Marth G, Yeh R, Minton M, Donaldson R, Li Q, Duan S, Davenport R, Miller R D and Kwok P Y 2001 Single-nucleotide polymorphisms in the public domain: how useful are they? Nat. Genet. 27 371-372
38. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans D G, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang H X, Szabo C, Devilee P, Goldgar D, Futreal P A, Nathanson K L, Weber B, Rahman N and Stratton M R 2002 CHEK2-Breast Cancer Consortium. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations; Nat. Genet. 31 55-59
39. Miller D P, Liu G, De Vivo I, Lynch T J, Wain J C, Su L and Christiani D C 2002 Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk; Cancer Res. 62 2819-2823
40. Mitrunen K and Hirvonen A 2003 Molecular epidemiology of sporadic breast cancer the role of polymorphic genes involved in oestrogen biosynthesis and metabolism; Mutat. Res. 544 9-41
41. Nishimoto I N, Pinheiro N A, Rogatto S R, Carvalho A L, de Moura R P, Caballero O L, Simpson A and Kowalski L P 2004 Alcohol dehydrogenase 3 genotype as a risk factor for upper aerodigestive tract cancers; Arch. Otolaryngol Head Neck Surg. 130 78-82
42. Park J, Chen L, Tockman M S, Elahi A and Lazarus P 2004 The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk; Pharmacogenetics 14 103-109
43. Paul L, Holm N V, Verkasalo P K, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki K 2000 Environmental and Heritable Factors in the Causation of Cancer - Analyses of Cohorts of Twins from Sweden, Denmark, and Finland; N. Engl. J. Med. 343 78-85
44. Peto J 2001 Cancer epidemiology in the last century and the next decade; Nature (London) 411 390-395
45. Peto J and Houlston R S 2001 Genetics and the common cancers; Eur. J. Cancer 37 S88-S96
46. Potter J D 1999 Colorectal cancer: molecules and populations; Natl. Cancer Inst. 91 916-932
47. Risch A, Wallace D M, Bathers S and Sim E 1995 Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer; Hum. Mol. Genet. 4 231-236
48. Ross R K, Jones P A and Yu M C 1996 Bladder cancer epidemiology and pathogenesis; Semin. Oncol. 23 536-545
49. Seow A, Zhao B, Lee E J, Poh W T, Teh M, Eng P, Wang Y T, Tan W C and Lee H P 2001 Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore; Carcinogenesis 22 673-677
50. Shekhar M P, Pauley R and Heppner G 2003 Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast; Breast Cancer Res. 5 130-135
51. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L et al 2000 Polymorpism of the DNA repair gene XRCC1 and risk of gastric cancer in Chinese population; Int. J. Cancer 88 601-606
52. Shu X O, Cai Q, Gao Y T, Wen W, Ji n F and Zheng W 2003 A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer; Cancer Epidemiol. Biomarkers Prev. 12 1462-1467
53. Slattery M L, Samowtiz W, Ma K, Murtaugh M, Sweeney C, Levin T R and Neuhausen S 2004 CYP1A1, cigarette smoking, and colon and rectal cancer; Am. J. Epidemiol. 160 842-852
54. Smits K M, Benhamou S, Garte S, Weijenberg M P, Alamanos Y, Ambrosone C, Autrup H, Autrup J L, Baranova H et al 2004 Association of metabolic gene polymorphisms with tobacco consumption in healthy controls; Int. J. Cancer 110 266-270
55. Sparks R, Ulrich C M, Bigler J, Tworoger S S, Yasui Y, Rajan K B, Porter P, Stanczyk F Z, Ballard-Barbash R, Yuan X, Lin M G, McVarish L, Aiello E J and McTiernan A 2004 UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumour receptor status in breast cancer patients; Breast Cancer Res. 6 R488-R498
56. Sturgis E M, Castillo E J, Li L, Zheng R, Eicher S A, Clayman G L, Strom S S, Spitz M R and Wei Q 1999 polymorphism of DNA repair genes XRCC1 in squamous cell carcinima of head and neck; Carcinogenesis 20 2125-2129
57. Sugiyama T 2004 Development of gastric cancer associated with Helicobacter pylori infection; Cancer Chemother Pharmacol. Aug. 7
58. Thompson P A and Ambrosone C 2000 Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer; J. Natl. Cancer Inst. Monogr. 27 125-134
59. Tiemersma E W, Bunschoten A, Kok F J, Glatt H, de Boer S Y and Kampman E 2004 Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas; Int. J. Cancer 108 97-103
60. Tomatis L 1990 Cancer: causes, occurrence and control (Lyon: International Agency for Research on Cancer)
61. Tworoger S S, Chubak J, Aiello E J, Ulrich C M, Atkinson C, Potter J D, Yasui Y, Stapleton P L, Lampe J W, Farin F M, Stanczyk F Z and McTiernan A 2004 Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women; Cancer Epidemiol. Biomarkers Prev. 13 94-101
62. van der Hel O L, Peelers P H, Hein D W, Doll M A, Grobbee D E, Kromhout D and Bueno de Mesquita H B 2003 NAT2 slow acetylation and GSTM1 null genotypes may increase post-menopausal breast cancer risk in long-term smoking women; Pharmacogenetics 13 399-407
63. Varley J and Haber D A 2003 Familial breast cancer and the hCHK21100delC mutation: assessing cancer risk; Breast Cancer Res. 5 123-125
64. Venter J C, Adams M D, Myers E W and Li P W et al 2001 The sequence of the human genome; Science 291 1304-1351
65. Warnakulasuriya KAAS, Robinson D and Evans H 2003 Multiple primary tumours following head and neck cancer in southern England during 1961-98; J. Oral Path. Med. 32 443
66. Wogan G N, Hecht S S, Felton J S, Conney A H and Loeb L A 2004 Environmental and chemical carcinogenesis; Semin. Cancer Biol. 14 473-486
67. Woodford-Richens K, Williamson J, Bevan S, Young J, Leggett B, Frayling I, Thway Y, Hodgson S, Kim J C, Iwama T, Novelli M, Sheer D, Poulsom R, Wright N, Houlston R and Tomlinson I 2000 Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium; Cancer Res. 60 2477-2482
68. Wu X, Zhao H, Suk R and Christiani D C 2004 Genetic susceptibility to tobacco-related cancer; Oncogene 23 6500-6523
69. Xing D, Qi J, Miao X, Lu W, Tan W and Lin D 2002 Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population; Int. J. Cancer 100 600-605
70. Yager J D 2000 Endogenous estrogens as carcinogens through metabolic activation; J. Natl. Cancer Inst. Monogr. 27 67-73
71. Yang G, Scherer S J, Shell S S, Yang K, Kim M, Lipkin M, Kucherlapati R, Kolodner R D and Edelmann W 2004 Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility; Cancer Cell 6 139-150
72. Zhu Y, Spitz M R, Amos C I, Lin J and Schabath M B 2004 An evolutionary perspective on Single-Nucleotide Polymorphism screening in molecular cancer epidemiology; Cancer Res. 64 2251-2257